Literature DB >> 10933695

Sequence variability of Borna disease virus: resistance to superinfection may contribute to high genome stability in persistently infected cells.

S Formella1, C Jehle, C Sauder, P Staeheli, M Schwemmle.   

Abstract

The RNA genome of Borna disease virus (BDV) shows extraordinary stability in persistently infected cell cultures. We performed bottleneck experiments in which virus populations from single infected cells were allowed to spread through cultures of uninfected cells and in which RNase protection assays were used to identify virus variants with mutations in a 535-nucleotide fragment of the M-G open reading frames. In one of the cell cultures, the major virus species (designated 2/1) was a variant with two point mutations in the G open reading frame. When fresh cells were infected with a low dose of a virus stock prepared from 2/1-containing cells, only a minority of the resulting persistently infected cultures contained detectable levels of the variant, whereas the others all seemed to contain wild-type virus. The BDV variant 2/1 remained stable in the various persistently infected cell cultures, indicating that the cells were resistant to superinfection by wild-type virus. Indeed, cells persistently infected with prototype BDV He/80 were also found to resist superinfection with strain V and vice versa. Our screen for mutations in the viral M and G genes of different rat-derived BDV virus stocks revealed that only one of four stocks believed to contain He/80 harbored virus with the original sequence. Two stocks mainly contained a novel virus variant with about 3% sequence divergence, whereas the fourth stock contained a mixture of both viruses. When the mixture was inoculated into the brains of newborn mice, the novel variant was preferentially amplified. These results provide evidence that the BDV genome is mutating more frequently than estimated from its invariant appearance in persistently infected cell cultures and that resistance to superinfection might strongly select against novel variants.

Entities:  

Mesh:

Year:  2000        PMID: 10933695      PMCID: PMC112318          DOI: 10.1128/jvi.74.17.7878-7883.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Borna disease virus infection in racing horses with behavioral and movement disorders.

Authors:  A L Berg; R Dörries; M Berg
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

2.  Cytokine expression in the rat central nervous system following perinatal Borna disease virus infection.

Authors:  C Sauder; J C de la Torre
Journal:  J Neuroimmunol       Date:  1999-04-01       Impact factor: 3.478

3.  Replication of reticuloendotheliosis viruses in cell culture: chronic infection.

Authors:  H M Temin; V K Kassner
Journal:  J Gen Virol       Date:  1975-06       Impact factor: 3.891

Review 4.  Borna disease: a persistent virus infection of the central nervous system.

Authors:  H Ludwig; L Bode; G Gosztonyi
Journal:  Prog Med Virol       Date:  1988

5.  Borna disease virus (BDV), a (zoonotic?) worldwide pathogen. A review of the history of the disease and the virus infection with comprehensive bibliography.

Authors:  R Dürrwald; H Ludwig
Journal:  Zentralbl Veterinarmed B       Date:  1997-05

6.  Increase of virus yields and releases of Borna disease virus from persistently infected cells.

Authors:  G Pauli; H Ludwig
Journal:  Virus Res       Date:  1985-02       Impact factor: 3.303

7.  Replication of Borna disease virus in cell cultures.

Authors:  S Herzog; R Rott
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

Review 8.  Rapid evolution of RNA genomes.

Authors:  J Holland; K Spindler; F Horodyski; E Grabau; S Nichol; S VandePol
Journal:  Science       Date:  1982-03-26       Impact factor: 47.728

9.  Borna disease virus in human brains with a rare form of hippocampal degeneration but not in brains of patients with common neuropsychiatric disorders.

Authors:  M Czygan; W Hallensleben; M Hofer; S Pollak; C Sauder; T Bilzer; I Blümcke; P Riederer; B Bogerts; P Falkai; M J Schwarz; E Masliah; P Staeheli; F T Hufert; K Lieb
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

Review 10.  Borna disease--neuropathology and pathogenesis.

Authors:  G Gosztonyi; H Ludwig
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

View more
  19 in total

1.  Analysis of borna disease virus trafficking in live infected cells by using a virus encoding a tetracysteine-tagged p protein.

Authors:  Caroline M Charlier; Yuan-Ju Wu; Sophie Allart; Cécile E Malnou; Martin Schwemmle; Daniel Gonzalez-Dunia
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  Varied persistent life cycles of Borna disease virus in a human oligodendroglioma cell line.

Authors:  Madiha S Ibrahim; Makiko Watanabe; J Alejandro Palacios; Wataru Kamitani; Satoshi Komoto; Takeshi Kobayashi; Keizo Tomonaga; Kazuyoshi Ikuta
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Borna disease virus accelerates inflammation and disease associated with transgenic expression of interleukin-12 in the central nervous system.

Authors:  Susanna Freude; Jürgen Hausmann; Markus Hofer; Ngan Pham-Mitchell; Iain L Campbell; Peter Staeheli; Axel Pagenstecher
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus.

Authors:  Mar Perez; Roberto Clemente; Clinton S Robison; E Jeetendra; Himangi R Jayakar; Michael A Whitt; Juan C de la Torre
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  Superinfection exclusion is an active virus-controlled function that requires a specific viral protein.

Authors:  Svetlana Y Folimonova
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

6.  The use of peptide arrays for the characterization of monospecific antibody repertoires from polyclonal sera of psychiatric patients suspected of infection by Borna Disease Virus.

Authors:  Martin Schwemmle; Christian Billich
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

7.  Borna disease virus RNA in immunocompromised patients in southwestern France.

Authors:  Emmanuelle Cotto; Didier Neau; Martine Cransac-Neau; Marc Auriacombe; Jean-Luc Pellegrin; Jean-Marie Ragnaud; Anne-Marie Fillet; Magali Belnard; Hervé Fleury; Marie-Edith Lafon
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Borna disease virus multiplication in mouse organotypic slice cultures is site-specifically inhibited by gamma interferon but not by interleukin-12.

Authors:  Gregor Friedl; Markus Hofer; Bernd Auber; Christian Sauder; Jürgen Hausmann; Peter Staeheli; Axel Pagenstecher
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Infection with strains of Citrus tristeza virus does not exclude superinfection by other strains of the virus.

Authors:  Svetlana Y Folimonova; Cecile J Robertson; Turksen Shilts; Alexey S Folimonov; Mark E Hilf; Stephen M Garnsey; William O Dawson
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

10.  A viral protein mediates superinfection exclusion at the whole-organism level but is not required for exclusion at the cellular level.

Authors:  María Bergua; Mark P Zwart; Choaa El-Mohtar; Turksen Shilts; Santiago F Elena; Svetlana Y Folimonova
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.